Home/Pipeline/Virtual PD‑L1 IHC

Virtual PD‑L1 IHC

Non‑Small Cell Lung Cancer

Service OfferingActive

Key Facts

Indication
Non‑Small Cell Lung Cancer
Phase
Service Offering
Status
Active
Company

About ViewsML Technologies

AI-powered virtual IHC platform that delivers rapid, cost‑effective biomarker analysis for oncology and precision medicine.

View full company profile

Therapeutic Areas

Other Non‑Small Cell Lung Cancer Drugs

DrugCompanyPhase
K‑001KalbePhase 3